Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.5187
-0.0489 (-8.62%)
At close: Jun 27, 2025, 4:00 PM
0.5352
+0.0165 (3.18%)
After-hours: Jun 27, 2025, 7:34 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $44.69 million as of June 27, 2025. Its market cap has decreased by -83.96% in one year.
Market Cap
44.69M
Enterprise Value
-67.76M
1-Year Change
-83.96%
Ranking
Category
Stock Price
$0.52
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $44.69M, a decrease of -95.75%. That is a compound annual growth rate of -54.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 48.90M | -43.06% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| Novo Nordisk | 331.06B |
| AbbVie | 322.03B |
| UnitedHealth Group | 280.41B |
| Abbott Laboratories | 233.80B |
| Novartis AG | 227.75B |
| AstraZeneca | 220.36B |